Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(18 sites)
Austria
Kaiser Franz Josef Hospital, Vienna (Wien) Belgium
Universitair Ziekenhuis Antwerpen, Edegem U.Z. Gasthuisberg, Leuven France
Institut Gustave Roussy, Villejuif Germany
University Medical Center, Freiburg im Breisgau Italy
Universita di Brescia, Brescia Instituto Scientifico H.S. Raffaele, Milano (Milan) Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano (Milan) Azienda Ospedaliera Di Parma, Parma University and I.R.C.C.S. Policlinico San Matteo, Pavia Ospedale di Circolo e Fondazione Macchi, Varese Ospedale Civile, Voghera (PV) Netherlands
Antoni van Leeuwenhoekhuis, Amsterdam Medisch Spectrum Twente, Enschede Leiden University Medical Center, Leiden Academisch Ziekenhuis Utrecht, Utrecht Portugal
Hospitais da Universidade de Coimbra (HUC), Coimbra Spain
Instituto Valenciano De Oncologia, Valencia